Calculating dose-averaged linear energy transfer in an analytical treatment planning system for carbon-ion radiotherapy.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 08 11 2022
received: 01 09 2022
accepted: 24 11 2022
pubmed: 18 12 2022
medline: 15 2 2023
entrez: 17 12 2022
Statut: ppublish

Résumé

Compelling evidence shows the association between the relative biological effectiveness (RBE) of carbon-ion radiotherapy (CIRT) and the dose averaged linear energy transfer (LETd). However, the ability to calculate the LETd in commercially available treatment planning systems (TPS) is lacking. This study aims to develop a method of calculating the LETd of CIRT plans that could be robustly carried out in RayStation (V10B, Raysearch, Sweden). The calculation used the fragment spectra in RayStation for the CIRT treatment planning. The dose-weighted averaging procedure was supported by the microdosimetric kinetic model (MKM). The MKM-based pencil beam dose engine (PBA, v4.2) for calculating RBE-weighted doses was reformulated to become a LET-weighted calculating engine. A separate module was then configured to inversely calculate the LETd from the absorbed dose of a plan and the associated fragment spectra. In this study, the ion and energy-specific LET table in the LETd module was further matched with the values decoded from the baseline data of the Syngo TPS (V13C, Siemens, Germany). The LETd distributions of several monoenergetic and modulated beams were calculated and validated against the values derived from the Syngo TPS and the published data. The differences in LETds of the monoenergetic beams between the new method and the traditional method were within 3% in the entrance and Bragg-peak regions. However, a larger difference was observed in the distal region. The results of the modulated beams were in good agreement with the works from the published literature. The method presented herein reformulates the MKM dose engine in the RayStation TPS to inversely calculate LETds. The robustness and accuracy were demonstrated.

Sections du résumé

BACKGROUND BACKGROUND
Compelling evidence shows the association between the relative biological effectiveness (RBE) of carbon-ion radiotherapy (CIRT) and the dose averaged linear energy transfer (LETd). However, the ability to calculate the LETd in commercially available treatment planning systems (TPS) is lacking.
PURPOSE OBJECTIVE
This study aims to develop a method of calculating the LETd of CIRT plans that could be robustly carried out in RayStation (V10B, Raysearch, Sweden).
METHODS METHODS
The calculation used the fragment spectra in RayStation for the CIRT treatment planning. The dose-weighted averaging procedure was supported by the microdosimetric kinetic model (MKM). The MKM-based pencil beam dose engine (PBA, v4.2) for calculating RBE-weighted doses was reformulated to become a LET-weighted calculating engine. A separate module was then configured to inversely calculate the LETd from the absorbed dose of a plan and the associated fragment spectra. In this study, the ion and energy-specific LET table in the LETd module was further matched with the values decoded from the baseline data of the Syngo TPS (V13C, Siemens, Germany). The LETd distributions of several monoenergetic and modulated beams were calculated and validated against the values derived from the Syngo TPS and the published data.
RESULTS RESULTS
The differences in LETds of the monoenergetic beams between the new method and the traditional method were within 3% in the entrance and Bragg-peak regions. However, a larger difference was observed in the distal region. The results of the modulated beams were in good agreement with the works from the published literature.
CONCLUSIONS CONCLUSIONS
The method presented herein reformulates the MKM dose engine in the RayStation TPS to inversely calculate LETds. The robustness and accuracy were demonstrated.

Identifiants

pubmed: 36527366
doi: 10.1002/acm2.13866
pmc: PMC9924117
doi:

Substances chimiques

Carbon 7440-44-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13866

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Cancers (Basel). 2018 Oct 23;10(11):
pubmed: 30360576
Phys Med Biol. 2010 Nov 21;55(22):6721-37
pubmed: 21030747
Adv Space Res. 1996;17(2):105-8
pubmed: 11540354
Radiol Phys Technol. 2018 Jun;11(2):242-247
pubmed: 29470773
Phys Med Biol. 2015 Apr 21;60(8):3271-86
pubmed: 25826534
Phys Med Biol. 2020 Jan 17;65(2):025006
pubmed: 31801119
J Appl Clin Med Phys. 2023 Feb;24(2):e13866
pubmed: 36527366
Phys Med Biol. 2012 Nov 21;57(22):7543-54
pubmed: 23104051
Radiother Oncol. 2020 Mar;144:30-36
pubmed: 31710941
Radiother Oncol. 2020 Dec;153:272-278
pubmed: 32898559
Radiother Oncol. 2021 Oct;163:209-214
pubmed: 34506829
Phys Med Biol. 2017 Dec 19;63(1):01TR02
pubmed: 28976361
Sci Rep. 2015 Nov 24;5:17016
pubmed: 26596243
Radiat Res. 1997 Jan;147(1):78-85
pubmed: 8989373
Acta Oncol. 2016 Dec;55(12):1512-1515
pubmed: 27827542
Clin Transl Radiat Oncol. 2019 Nov 27;21:19-24
pubmed: 31886424
Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):201-10
pubmed: 10219815
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):779-791
pubmed: 32504659
Phys Med Biol. 2000 Nov;45(11):3319-30
pubmed: 11098906

Auteurs

Weiwei Wang (W)

Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Institute of Modern Physics, Applied Ion Beam Physics Laboratory, Fudan University, Shanghai, China.

Ping Li (P)

Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.

Kambiz Shahnazi (K)

Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.

Xiaodong Wu (X)

Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.

Jingfang Zhao (J)

Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH